Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $71.74M in the quarter ending September 30, 2024, a decrease of -15.28%. This brings the company's revenue in the last twelve months to $277.76M, down -3.02% year-over-year. In the year 2023, Fulgent Genetics had annual revenue of $289.21M, down -53.27%.

• Revenue (ttm): $277.76M
• Revenue Growth: -3.02%
• P/S Ratio: 1.87
• Revenue / Employee: $234,595
• Employees: 1,184
• Market Cap: 522.63M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	289.21M	-329.76M	-53.27%
Dec 31, 2022	618.97M	-373.62M	-37.64%
Dec 31, 2021	992.58M	570.87M	135.37%
Dec 31, 2020	421.71M	389.18M	1,196.46%
Dec 31, 2019	32.53M	11.18M	52.35%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.